NeoGenomics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
NeoGenomics, Inc. (NEO) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $15.27 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-07-28
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $15.27M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $22.90M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $7.63M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $15.27M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $15.27M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $22.90M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $7.63M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $15.27M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $24.98M 10-Q · filed 2025-04-29 |
| 2024-09-30 | $8.36M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $16.72M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $25.09M 10-Q · filed 2024-04-30 |
| 2023-09-30 | $8.78M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $17.57M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $26.35M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $8.49M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $16.98M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $25.39M 10-Q · filed 2022-05-09 |
| 2021-09-30 | $8.46M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $17.33M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $7.37M 10-Q · filed 2021-05-06 |
| 2020-09-30 | $2.47M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $4.93M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $7.40M 10-Q · filed 2020-04-29 |
| 2019-09-30 | $2.45M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $5.01M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $7.55M 10-Q · filed 2019-05-08 |
| 2018-09-30 | $1.42M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $2.84M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $4.27M 10-Q · filed 2018-05-08 |
| 2017-09-30 | $1.80M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $3.44M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $5.17M 10-Q · filed 2017-05-09 |
| 2016-09-30 | $1.82M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $3.64M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $5.25M 10-Q · filed 2016-05-10 |
| 2015-09-30 | $93.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $186.00K 10-Q · filed 2015-07-31 |
| 2015-03-31 | $278.00K 10-Q · filed 2015-05-11 |
| 2014-09-30 | $92.00K 10-Q · filed 2014-11-04 |
| 2014-06-30 | $112.00K 10-Q · filed 2014-07-29 |
| 2014-03-31 | $167.00K 10-Q · filed 2014-05-12 |
| 2013-09-30 | $56.00K 10-Q · filed 2013-10-30 |
| 2013-06-30 | $112.00K 10-Q · filed 2013-08-02 |
| 2013-03-31 | $167.00K 10-Q · filed 2013-05-13 |
| 2012-09-30 | $56.00K 10-Q · filed 2012-11-05 |
| 2012-06-30 | $112.00K 10-Q/A · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |